Cargando…

Nicotine Reduction in Cigarettes: Literature Review and Gap Analysis

BACKGROUND: The US Food and Drug Administration (FDA) is considering reducing nicotine levels in cigarettes to “minimally or non-addictive levels.” However, important research gaps remain, and the FDA must determine when the available research is sufficient to support moving forward. METHODS: The au...

Descripción completa

Detalles Bibliográficos
Autores principales: Berman, Micah L, Glasser, Allison M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6939782/
https://www.ncbi.nlm.nih.gov/pubmed/31867659
http://dx.doi.org/10.1093/ntr/ntz162
_version_ 1783484252621373440
author Berman, Micah L
Glasser, Allison M
author_facet Berman, Micah L
Glasser, Allison M
author_sort Berman, Micah L
collection PubMed
description BACKGROUND: The US Food and Drug Administration (FDA) is considering reducing nicotine levels in cigarettes to “minimally or non-addictive levels.” However, important research gaps remain, and the FDA must determine when the available research is sufficient to support moving forward. METHODS: The authors conducted a systematic review of research articles in PubMed relating to nicotine reduction. Building on a review of risk assessment best practices, the authors also developed a risk assessment framework for tobacco regulation and used it to guide a gap analysis of nicotine reduction research. RESULTS: The final sample consisted of 78 articles. The majority examined either nicotine dependence on very low nicotine cigarettes (VLNCs) or markers of potential health effects of using VLNCs. One-third of the identified articles reported results from four large randomized controlled trials (RCTs). While these studies report promising results and suggest that a nicotine reduction rule would be a powerful tool to reduce cigarette smoking, our gap analysis suggests that there is a need for studies that better reflect the use and availability of a wide range of tobacco/nicotine products and the potential for dual- or multi-product use. CONCLUSION: The current body of research on nicotine reduction is weighted towards RCTs, which is appropriate for a policy that has not yet been implemented anywhere in the world. The FDA must consider a wide range of factors that may impact a product standard’s public health impact, including those difficult to assess in RCTs, such as a nicotine reduction rule’s impact on smoking initiation and relapse. IMPLICATIONS: This systematic review presents a gap analysis based on a risk assessment framework to help identify remaining research priorities to inform FDA’s potential product standard to reduce nicotine levels in cigarettes. Quickly addressing those gaps would support the FDA’s effort to develop a nicotine reduction product standard that will be effective and withstand legal challenges.
format Online
Article
Text
id pubmed-6939782
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-69397822020-01-07 Nicotine Reduction in Cigarettes: Literature Review and Gap Analysis Berman, Micah L Glasser, Allison M Nicotine Tob Res Reactions to a Potential Nicotine Reduction Policy BACKGROUND: The US Food and Drug Administration (FDA) is considering reducing nicotine levels in cigarettes to “minimally or non-addictive levels.” However, important research gaps remain, and the FDA must determine when the available research is sufficient to support moving forward. METHODS: The authors conducted a systematic review of research articles in PubMed relating to nicotine reduction. Building on a review of risk assessment best practices, the authors also developed a risk assessment framework for tobacco regulation and used it to guide a gap analysis of nicotine reduction research. RESULTS: The final sample consisted of 78 articles. The majority examined either nicotine dependence on very low nicotine cigarettes (VLNCs) or markers of potential health effects of using VLNCs. One-third of the identified articles reported results from four large randomized controlled trials (RCTs). While these studies report promising results and suggest that a nicotine reduction rule would be a powerful tool to reduce cigarette smoking, our gap analysis suggests that there is a need for studies that better reflect the use and availability of a wide range of tobacco/nicotine products and the potential for dual- or multi-product use. CONCLUSION: The current body of research on nicotine reduction is weighted towards RCTs, which is appropriate for a policy that has not yet been implemented anywhere in the world. The FDA must consider a wide range of factors that may impact a product standard’s public health impact, including those difficult to assess in RCTs, such as a nicotine reduction rule’s impact on smoking initiation and relapse. IMPLICATIONS: This systematic review presents a gap analysis based on a risk assessment framework to help identify remaining research priorities to inform FDA’s potential product standard to reduce nicotine levels in cigarettes. Quickly addressing those gaps would support the FDA’s effort to develop a nicotine reduction product standard that will be effective and withstand legal challenges. Oxford University Press 2019-12 2019-12-23 /pmc/articles/PMC6939782/ /pubmed/31867659 http://dx.doi.org/10.1093/ntr/ntz162 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of the Society for Research on Nicotine and Tobacco. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Reactions to a Potential Nicotine Reduction Policy
Berman, Micah L
Glasser, Allison M
Nicotine Reduction in Cigarettes: Literature Review and Gap Analysis
title Nicotine Reduction in Cigarettes: Literature Review and Gap Analysis
title_full Nicotine Reduction in Cigarettes: Literature Review and Gap Analysis
title_fullStr Nicotine Reduction in Cigarettes: Literature Review and Gap Analysis
title_full_unstemmed Nicotine Reduction in Cigarettes: Literature Review and Gap Analysis
title_short Nicotine Reduction in Cigarettes: Literature Review and Gap Analysis
title_sort nicotine reduction in cigarettes: literature review and gap analysis
topic Reactions to a Potential Nicotine Reduction Policy
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6939782/
https://www.ncbi.nlm.nih.gov/pubmed/31867659
http://dx.doi.org/10.1093/ntr/ntz162
work_keys_str_mv AT bermanmicahl nicotinereductionincigarettesliteraturereviewandgapanalysis
AT glasserallisonm nicotinereductionincigarettesliteraturereviewandgapanalysis